Conference
The proportion and characterization of patients with metastatic renal cell carcinoma who are never treated or have delayed treatment with targeted therapy: Results from a large prospective cohort.
Abstract
424
Background: The proportion and characterization of patients (pts) with metastatic renal cell carcinoma (mRCC) who never start or delay starting targeted therapy (TT) is unknown. It is important to understand and characterize these pts. Methods: Data from the Canadian Kidney Cancer information system (CKCis) database were utilized. CKCis data were collected prospectively from 14 REB-approved academic centers in Canada. The …
Authors
Bains P; Heng DYC; Knox JJ; Bjarnason GA; Kollmannsberger CK; Hotte SJ; Kapoor A; Vanhuyse M; Reaume MNN; Czaykowski P
Volume
33
Pagination
pp. 424-424
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
March 1, 2015
DOI
10.1200/jco.2015.33.7_suppl.424
Conference proceedings
Journal of Clinical Oncology
Issue
7_suppl
ISSN
0732-183X